Key statistics
On Friday, Exagen Inc (E08A:BER) closed at 2.52, -24.10% below its 52-week high of 3.32, set on Aug 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.54 |
---|---|
High | 2.60 |
Low | 2.46 |
Bid | 2.58 |
Offer | 2.76 |
Previous close | 2.56 |
Average volume | 0.00 |
---|---|
Shares outstanding | 17.39m |
Free float | 8.71m |
P/E (TTM) | -- |
Market cap | 51.46m USD |
EPS (TTM) | -0.9689 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 19:21 BST.
More ▼
Announcements
- Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
- Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
- Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
- Exagen to Announce Second Quarter 2024 Results on August 5, 2024
- Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
- Exagen Announces Campaign for Lupus Awareness Month
- Exagen to Announce First Quarter 2024 Results on May 13, 2024
- Exagen Inc. Announces Changes to the Board of Directors
- Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
More ▼